Frontlight ResearchEarly access
Trial site
Thoraxklinik At University Of Heidelberg
- 5running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- High blood pressure2 trials
- Idiopathic pulmonary fibrosis2 trials
- Pulmonary arterial hypertension2 trials
- Congenital heart disease1 trial
- COPD1 trial
- HIV1 trial
- Neuroendocrine tumours1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC4 trials
- Bristol-Myers Squibb2 trials
- Bristol-Myers Squibb Services Unlimited Company2 trials
- Boehringer Ingelheim1 trial
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
Completed
Phase 3 study of SBRT ± pembrolizumab for participants with unresectable Stage I or II NSCLC
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026